Store

Home | Store | The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition

The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition

Publication Date: January 25, 2021

SKU: 21-022

Tags: COVID-19, Diagnostic Instruments, Infectious Disease Testing Instruments, Oncology and Cancer, Point-of-Care (POC) Testing

Pages: 595

SKU: 21-022

Explore the comprehensive analysis of the POC testing market, its growth prospects, and the key players driving innovation in this essential segment of the healthcare industry in Kalorama Information’s report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition.

By the middle of the decade, the global point-of-care (POC) testing market is expected to reach an impressive $45 billion annually. This growth is not unexpected, considering the substantial investments made globally in both professional and self-administered POC diagnostic testing. In 2020, sales of POC testing reached $29 billion, with the COVID-19 pandemic significantly influencing this market with a surge in new tests.

 

Impact of COVID-19:

The pandemic caused disruptions in certain segments due to lockdowns, reduced physician visits, and a decline in elective and outpatient surgeries. However, the POC market is anticipated to resume its pre-pandemic growth trajectory across all segments. Certain areas are expected to see substantial advancements from 2021-2025, culminating in a global market size of nearly $45 billion by 2025, with an 8.9% growth rate over the forecast period from 2020 to 2025.

 

Market Breakdown:

  • Global POC Test Market (2020-2025)
  • POC Testing Market by Product Category (2020):
    • Self-Testing
    • Professional Testing
    • Total
  • POC Self-Testing Market by Product Category (2020):
    • Glucose (including CGM)
    • Pregnancy & Fertility
    • Fecal Occult Blood
    • Rapid Coagulation
    • Drugs of Abuse
    • Urine
    • Infectious Disease
    • Lipid
    • Total
  • POC Professional Testing Market by Product Subcategory (2020):
    • Drugs of Abuse
    • Glucose (includes HbA1c)
    • Blood & Electrolytes
    • Infectious Disease
    • Rapid Coagulation
    • Fecal Occult Blood
    • Cardiac Markers
    • Lipid
    • Pregnancy & Fertility
    • Miscellaneous
    • Urine
    • Cancer Tumor Markers
    • Total

 

End-User Analysis (2020):

  • Hospitals
  • Others

 

Technology and Regional Analysis:

  • By Technology (2020):
    • LFA
    • Biosensors
    • Analyzers
    • Strips
  • Regional Breakdown (2020):
    • United States
    • Europe
    • Japan
    • ROW
  • European Region Analysis (2020):
    • W. Europe
    • E. Europe
    • Total
  • Rest of World Analysis (2020):
    • Latin America and Mexico
    • China
    • Australia
    • South Korea
    • India
    • Other

 

Segment Size and Growth: POC test devices have driven substantial growth in the diagnostics market over the past decade. The pursuit of CLIA waiver status and CE Mark for POC devices has been pivotal. Advances in technology are enabling POC devices to deliver lab-quality results, which can be seamlessly integrated into information systems and electronic medical records, enhancing patient care.

 

Detailed Market Segments:

  • Global POC Glucose Testing Market (2020-2025)
  • Global POC Blood and Electrolytes Testing Market (2020-2025)
  • Global Rapid Coagulation Testing Market (2020-2025)
  • Total Rapid Cardiac Markers Tests Market (2020-2025)
  • Global POC Drugs of Abuse Testing Market (2020-2025)
  • Global POC Pregnancy and Fertility Testing Market (2020-2025)
  • Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market (2020-2025)
  • Global POC Infectious Disease Testing Market (2020-2025)
  • Global POC Lipid Testing Market (2020-2025)
  • Global POC Cancer Testing Market (2020-2025)
  • Global POC Urine Testing Market (2020-2025)
  • Global Miscellaneous POC Testing Market (2020-2025)

 

Emerging Trends and Future Outlook: Wearable devices integrating POC testing are becoming increasingly popular, streaming health data directly into clinical data repositories and electronic health records (EHR). However, cost pressures and regulatory changes may impact the market trajectory, particularly in Europe and the United States.

 

POC Testing Applications:

  • Hospitals
  • Physicians’ offices
  • Hospital clinics
  • Rural health clinics
  • Student health clinics
  • Retail clinics
  • Pharmacies
  • Homes
  • Nursing homes
  • Prisons

 

Corporate Profiles: The report also includes profiles of leading and innovative competitors in the POC testing market, offering insights into their strategies and product offerings.

 

For further details and to purchase directly, please contact us.

Table of Contents

1: Executive Summary

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
      • Table 1-1: Global POC Test Market, 2020-2025 (in millions $ at manufacturer level)
  • Trends Affecting the Market
  • Competitive Outlook
  • Market Conclusions
    • Conclusion One – POC market transformed by technological progress
    • Conclusion Two –POC Molecular Diagnostics continue making inroads
    • Conclusion Three – Prevention and early detection at nexus of POC development
    • Conclusion Four- Wearables continue to influence POC market
    • Conclusion Four – Test cost will continue to be an issue worldwide
    • Conclusion Five– Reimbursement and economic conditions still hot issue
    • Conclusion Six – Rising demand will drive POC market in RoW markets
    • Conclusion Seven – New venues – urgent & retail care
    • Conclusion Eight – COVID-19’s Positive Effect

2: Introduction and Overview

  • Point-of-Care Diagnostics Testing
  • Industry Regulations
  • POC Industry Drivers
    • Patient focused drivers
    • Medical/Healthcare related drivers
    • Technology drivers
    • Economic drivers
    • Other drivers
  • POC Test Types
    • Blood
    • Urine
    • Saliva
    • Hair
    • Optical Technologies
    • Breath
  • Conditions Evaluated by POC Diagnostic Testing
    • Cancer
    • Cardiovascular Disease
    • Diabetes
    • Drug Abuse
    • Infectious Disease
    • Osteoporosis
    • Pregnancy and Fertility

3: POC Blood Glucose Tests

  • Types of Blood Glucose Testing
    • Fasting Blood Sugar (FBS)
    • 2-Hour Postprandial Blood Sugar (PPBS)
    • Random Blood Sugar
    • Glucose Tolerance Test
    • Glucose Urine Test
    • Glycated Hemoglobin (HbA1c)
  • Products
    • Blood Glucose Self-Testing
      • Table 3-1: Selected Glucose Self-Test Meter Innovations
      • Table 3-2: Selected Apps and Glucose Management IT
    • Continuous Self-Testing
    • Glycated Hemoglobin Tests
      • Table 3-3: Selected POC HbA1c Devices
    • Professional
  • Market Size and Growth
      • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
      • Table 3-5: Global POC Diabetes Sales by Test Category, 2020-2025 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
    • Regional Analysis
      • Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2020
    • POC Glucose Self-Testing
      • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2020-2025 (in millions $ at manufacturer level)
      • Table 3-7: Global POC Continuous Glucose Self-Testing Market 2020-2025 (in millions $ at manufacturer level)
    • POC Glucose Professional Testing
      • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2020-2025 (in millions $ at manufacturer level)
      • Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2020-2025 (in millions $ at manufacturer level)
  • COVID-19 Impact
  • Competitive Analysis
      • Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM,HbA1c) Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
      • Figure 3-2: Global POC Glucose Test Manufacturers by Percent, 2020

4: POC Blood and Electrolytes Testing Market

  • Types of Blood and Electrolytes Tests
    • Hemoglobin/Hematocrit
    • WBC and Other
    • Blood Gases
    • Electrolytes
  • Products
      • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2020
      • Table 4-2: Selected POC Hematology Analyzer Systems, 2020
    • Developments
  • Market Size and Growth
      • Table 4-3: Global POC Blood and Electrolytes Testing( Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC, Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
      • Table 4-4: Global POC Blood & Electrolytes Revenues by Test Category, 2020-2025 ($ millions)
    • Regional Analysis
      • Figure 4-1: POC Blood and Electrolytes Testing Regional Market (US, Europe, Japan, Rest of World) Analysis 2020
    • POC Blood and Electrolyte Self-Testing
      • Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • POC Blood and Electrolyte Professional Testing
      • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
      • Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
      • Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers by Percent, 2020

5: POC Rapid Coagulation

  • Products
      • Table 5-1: Selected POC Coagulation Test Innovations
    • Platelet Testing
      • Table 5-2: Selected Platelet Activity Test Innovations
  • Market Size and Growth
      • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Regional Analysis
      • Figure 5-1: POC Rapid Coagulation Testing Regional (US, Europe, Japan, Rest of World) Market Analysis 2020
    • POC Rapid Coagulation Self-Testing
      • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • POC Rapid Coagulation Professional Testing
      • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
      • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions$)
      • Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers, 2020

6: POC Rapid Cardiac Markers

  • Products
  • Market Size and Growth
      • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Regional Analysis
      • Figure 6-1: POC Rapid Cardiac Markers Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
  • COVID-19 Impact
  • Competitive Analysis
      • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
      • Figure 6-2: Global POC Cardiac Test Manufacturers by Percent, 2020

7: POC Substance Abuse

  • Overview
  • Products
    • Urine
    • Oral
    • Blood
    • Hair
  • Market Size and Growth
      • Table 7-1: Global POC Drugs of Abuse Testing (mainly critical care) Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Regional Analysis
      • Figure 7-1: POC Substance Abuse Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
    • POC Drugs of Abuse Self-Testing
      • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2020-2025
    • POC Drugs of Abuse Professional Testing
      • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
      • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2019
      • Figure 7-2: Global POC Drug of Abuse Testing Manufacturers by Percent, 2020

8: POC Pregnancy and Fertility Testing

  • Products
      • Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay
  • Market Size and Growth
      • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Regional Analysis
      • Figure 8-1: POC Pregnancy and Fertility Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
    • POC Pregnancy and Fertility Self-Testing
      • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • POC Pregnancy and Fertility Professional Testing
      • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
      • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
      • Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2020

9: POC Colon Cancer Screening/Fecal Occult Blood Testing

  • Products
      • Table 9-1: Selected POC Colon Cancer Tests
  • Market Size and Growth
      • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Regional Analysis
      • Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
    • POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
      • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
      • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
      • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
      • Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers by Percent, 2020

10: POC Infectious Disease Testing

  • Products
    • HIV and Hepatitis
    • Respiratory
    • STD
    • Tropical Diseases
    • Lyme Disease
    • TB
    • Zika
    • Hospital Acquired Infections and Sepsis
      • Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
    • COVID-19
  • Market Size and Growth
      • Table 10-2: Global POC Infectious Disease (including COVID-19) Testing Market Analysis: 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Regional Analysis
      • Figure 10-1: POC Infectious Disease (including COVID-19) Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
    • POC Infectious Disease Self-Testing
      • Table 10-3: POC Infectious Disease Self-Testing(including COVID-19) Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • POC Infectious Disease Professional Testing
      • Table 10-4: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • POC Infectious Disease Testing by Disease Type
      • Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2020 (in millions $)
      • Figure 10-2 : Global POC Infectious Disease (COVID-19, Influenza, HIV, STD, Hepatitis, Malaria, C. Diff, E. coli, H. pylori, Home, Others) Percent by Disease Type 2020
      • Figure 10-3: Global Selected POC Infectious Disease (COVID-19, Respiratory, HIV, STD, Hepatitis, C. Diff) Percent by End-user (Hospital including reference labs, physician office labs (POL) and nursing homes, pharmacy, home use and others) in 2020
  • COVID-19 Impact
  • Competitive Analysis
      • Table 10-6: Global POC Infectious Disease including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
      • Figure 10-4: Global POC Infectious Disease Test Manufacturers by Percent, 2020

11: POC Lipid Testing

  • Products
  • Market Size and Growth
      • Table 11-1: Global POC Lipid Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Regional Analysis
      • Figure 11-1: POC Lipid Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
    • POC Lipid Self-Testing
      • Table 11-2: POC Lipid Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • POC Lipid Professional Testing
      • Table 11-3: POC Lipid Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
      • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
      • Figure 11-2: Global POC Lipid Testing Manufacturers by Percent, 2020

12: POC Cancer Tumor Marker Testing

  • Products
      • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
  • Market Size and Growth
      • Table 12-2: Global POC Cancer Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Regional Analysis
      • Figure 12-1: POC Cancer Tumor Marker Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
  • COVID-19 Impact
  • Competitive Analysis
      • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
      • Figure 12-2: Global POC Cancer Testing Manufacturers by Percent, 2020

13: POC Urine Testing

  • Products
  • Market Size and Growth
      • Table 13-1: Global POC Urine Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Regional Analysis
      • Figure 13-1: POC Urine Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
    • POC Urine Self-Testing
      • Table 13-2: POC Urine Self-Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • POC Urine Test Professional Testing
      • Table 13-3: POC Urine Professional Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
      • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
      • Figure 13-2: Global POC Urine Strip Testing Manufacturers by Percent, 2020

14: Miscellaneous POC Testing

  • Microbiology
  • TSH
  • Allergy
  • Autoimmune
  • Others
  • Market Size and Growth
      • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
      • Table 14-2: Global POC Miscellaneous Sales by Test Category, 2020-2025 (Microbiology, TSH, Allergy, Autoimmune, Others TOTAL; $ millions)
    • Regional Analysis
      • Figure 14-1: POC Miscellaneous Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2020
  • COVID-19 Impact

15: Issues and Trends

  • Overview
  • Wearables
      • Table 15-1: Selected Wearable Devices
  • Mobile Healthcare Technologies
  • Telehealth
  • Patient-centered Healthcare
  • Breath Test Advances
      • Table 15-2: Selected Disease Markers in Exhaled Breath
  • Regulatory Hurdles
  • Reimbursement Challenges
  • PAMA
  • Competition
  • POC and Molecular Diagnostics
      • Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
  • Funding Developments in POC
  • POC and Biosensors and Microfluidics
      • Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2020
      • Table 15-5: Selected Biochip and Biosensor Players, 2020
  • China as a POC Market
  • Emerging POC Technologies
  • POC Connectivity
  • Multiplexed POC Testing
      • Figure 15-6: Multiplexed POC Testing Schematic
  • The Emergence of Non-invasive Technologies
    • Saliva and Swab
    • Optical Techniques
    • Near-infrared Scanning
    • Volatolomics
  • POC and Antibiotic Resistance Concern

16: Total Global POC Testing Market and Competitor Analysis

  • Market Overview
      • Table 16-1: Global POC Test Market, 2020-2025 (in millions $ at manufacturer level)
  • Market Analysis by Product Categories
      • Table 16-2: Global POC Testing Market Analysis by Product Category, 2020 (in millions $)
  • Market Analysis by Subcategory
    • POC Self-Testing
      • Table 16-3: Global POC Self-Testing Market Analysis by Product Category, 2020 (in millions$)
      • Figure 16-1: Global POC Self-Testing Market Analysis by Product Category, 2020 (by %)
    • POC Professional Testing
      • Table 16-4: Global POC Professional Testing Market Analysis by Product Subcategory, 2020 (in millions$)
      • Figure 16-2 : Global POC Professional Testing Market Analysis by Product Subcategory, 2020 (by %)
    • POC Testing by End-Use
      • Figure 16-3: POC Testing by End-user, 2020
  • Market by Device Technology
      • Figure 16-4: Global POC Market by Technology by Sales 2020
  • Market Analysis by Country
    • United States
      • Table 16-5: US POC Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Europe
      • Table 16-6: Europe POC Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
      • Table 16-7: Global POC Testing Market Analysis by European Region, 2020 (in millions $)
      • Figure 16-5: Europe POC Testing Percentage Participation, by Country, 2020
    • Japan
      • Table 16-8: Japan POC Testing Market Analysis, 2020-2025 (in millions of dollars at the manufacturer’s level)
    • Rest of World
      • Table 16-9: Global POC Testing Market Analysis by Rest of World Region/Country, 2020 (in millions $)
      • Figure 16-6: Global POC Testing Market Analysis by Rest of World Region/Country, 2020
      • Table 16-10: Global POC Testing Analysis by Region/Country, 2020 (in millions $)
      • Figure 16-7: Global POC Testing Market Analysis Percent by Region/Country, 2020
  • COVID-19 Impact
  • Competitive Analysis
      • Table 16-11: Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2020 (in millions $)
      • Figure 16-8: Global POC Testing Market Share by Leading Suppliers, 2020

17: Corporate Profiles

  • Overview
  • 1 Step Detect Associates, LLC
      • Table 17-1: 1-Step Detect Associates Corporate Summary
    • Company Overview
    • Products
  • Abaxis, Inc.
      • Table 17-2: Abaxis Corporate Summary
    • Company Overview
    • Products
  • Abbott Laboratories
      • Table 17-3: Abbott Corporate Summary
    • Company Overview
    • Alere Acquisition Update
    • Products
    • COVID-19
    • Performance Review
      • Table 17-4: Abbott Revenues 2018-2020 (in millions $)
  • Abingdon Health, Ltd.
      • Table 17-5: Abingdon Health Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • AccessBio, Inc.
      • Table 17-6: AccessBio Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • AccuBioTech Co, Ltd.
      • Table 17-7: AccuBioTech Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • ACON Laboratories, Inc
      • Table 17-8: ACON Laboratories Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Aerscher Diagnostics, LLC
      • Table 17-9: Aerscher Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Akers Biosciences, Inc.
      • Table 17-10: Akers Biosciences Corporate Summary
    • Company Overview
    • Products
  • Alfa Scientific Designs, Inc
      • Table 17-11: Alfa Scientific Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • American Bio Medica Corporation
      • Table 17-12: American Bio Medica Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Performance Review
      • Table 17-13: American Bio Medica Corporation Revenue (2017-2020) ($ millions)
  • Arlington Scientific, Inc.
      • Table 17-14: Arlington Scientific Corporate Summary
    • Company Overview
    • Products
  • Arkray, Inc.
      • Table 17-15: Arkray Corporate Summary
    • Company Overview
    • Products
  • Artron Laboratories, Inc
      • Table 17-16: Artron Laboratories Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Ascensia Diabetes Care Holdings AG
      • Table 17-17: Ascensia Diabetes Care Corporate Summary
    • Company Overview
    • Products
  • Atlas Link Biotech Co., Ltd
      • Table 17-18: Atlas Link Biotech Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Ativa Medical Corporation
      • Table 17-19: Ativa Medical Corporate Summary
    • Company Overview
    • Products
  • Audit Diagnostics
      • Table 17-20: Audit Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Autobio Diagnostics Co., Ltd
      • Table 17-21: Autobio Diagnostics Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Augurix Diagnostic
      • Table 17-22: Augurix Diagnostic Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Axxin
      • Table 17-23: Axxin Corporate Summary
    • Company Overview
    • Products
  • Beckman Coulter, Inc
      • Table 17-24: Beckman Coulter Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Company Financials
      • Table 17-25: Beckman Coulter Revenue (2017-2020) ($ millions)
  • Becton Dickinson (BD)
      • Table 17-26: BD Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 17-27: BD Corporation Revenue (2017-2020) ($ millions)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
      • Table 17-28: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Bhat Bio-Tech India Private Ltd. (BBI)
      • Table 17-29: Bhat Bio-Tech India Private Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • binx health
      • Table 17-30: binx health Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • bioLytical Laboratories
      • Table 17-31: bioLytical Laboratories Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Biomerica, Inc.
      • Table 17-32: Biomerica Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Company Financials
      • Table 17-33: Biomerica Corporation Revenue (2017-2020) ($ millions)
  • BioMedomics, Inc
      • Table 17-34: BioMedomics Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Biomeme, Inc
      • Table 17-35: Biomeme Corporate Summary
    • Company Overview
    • Products
  • bioMerieux SA
      • Table 17-36: bioMerieux SA Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Company Financials
      • Table 17-37: bioMerieux Revenues (2017-2020) ($ millions)
  • Biophor Diagnostics, Inc
      • Table 17-38: Biophor Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Bio-Rad Laboratories Inc.
      • Table 17-39: Bio-Rad Labs Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 17-40: Bio-Rad Corporation Revenue (2017-2020) ($ millions)
  • Biotron Diagnostics, Inc.
      • Table 17-41: Biotron Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Biosensia Ltd.
      • Table 17-42: Biosensia Corporate Summary
    • Company Overview
    • Products
  • Boditech Med Inc
      • Table 17-43: Boditech Med Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Boson Biotech Co. Ltd
      • Table 17-44: Boson Biotech Corporate Summary
    • Company Overview
    • Products
  • BNTX Inc.
      • Table 17-45: BNTX Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Calypte Biomedical Corporation
      • Table 17-46: Calypte Biomedical Corporate Summary
    • Company Overview
    • Products
  • Cepheid, Inc
      • Table 17-47: Cephid Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Performance Review
      • Table 17-48: Cepheid Revenues (2017-2020) ($ millions)
  • Chembio Diagnostics, Inc.
      • Table 17-49: Chembio Diagnostic Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Performance Review
      • Table 17-50: Chembio Diagnostics Revenues (2017-2020) ($ millions)
  • Church & Dwight Co. Inc
      • Table 17-51: Church & Dwight Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-52: Church and Dwight Revenues (2017-2020) ($ millions)
  • Clarity Diagnostics, LLC
      • Table 17-53: Clarity Diagnostics Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Confirm Biosciences
      • Table 17-54: Confirm Biosciences Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • CTK Biotech, Inc.
      • Table 17-55: CTK Biotech Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Danaher Corporation
      • Table 17-56: Danaher Corporation Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 17-57: Danaher Revenues (2017-2020) ($ millions)
  • Dexcom, Inc
      • Table 17-58: Dexcom Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-59: Dexcom Revenues (2017-2020) ($ millions)
  • DIALAB GmbH
      • Table 17-60: DIALAB Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • DiaSys Diagnostic Systems GmbH
      • Table 17-61: DiaSys Diagnostic Systems Corporate Summary
    • Company Overview
    • Products
  • DxGen Corp.
      • Table 17-62: DxGen Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Diazyme Laboratories, Inc.
      • Table 17-63: Diazyme Laboratories Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • DNA Electronics Ltd. (DNAe)
      • Table 17-64: DNA Electronics Corporate Summary
    • Company Overview
    • Products
  • Dragerwerk AG & Co. KGaA
      • Table 17-65: Dragerwerk Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 17-66: Dragerwerk Revenues (2017-2020) ($ millions)
  • Dr. Fooke-Achterrath Laboratorien GmbH
      • Table 17-67: Dr. Fooke-Achterrath Laboratorien Corporate Summary
    • Company Overview
    • Products
  • DRG International, Inc.
      • Table 17-68: DRG International Corporate Summary
    • Company Overview
    • Products
  • Eiken Chemical Co Ltd.
      • Table 17-69: Eiken Chemical Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Performance Review
      • Table 17-70: Eiken Chemical Revenues (2017-2020) ($ millions)
  • EKF Diagnostics Holdings plc
      • Table 17-71: EKF Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-72: EKF Diagnostics Revenues (2017-2020) ($ millions)
  • ELITechGroup, Inc.
      • Table 17-73: ELITechGroup Corporate Summary
    • Company Overview
    • Products
  • Enterix, Inc. (Clinical Genomics)
      • Table 17-74: Enterix Corporate Summary
    • Company Overview
    • Products
  • Eurobio Scientific
      • Table 17-75: Eurobio Scientific Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Eurolyser Diagnostica GmbH
      • Table 17-76: Eurolyser Diagnostica Corporate Summary
    • Company Overview
    • Products
  • Everlywell
      • Table 17-77: Everlywell Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Exact Sciences
      • Table 17-78: Exact Sciences Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-79: Exact Sciences Revenues (2017-2020) ($ millions)
  • EY Laboratories
      • Table 17-80: EY Laboratories Corporate Summary
    • Company Overview
    • Products
  • Fio Corporation
      • Table 17-81: Fio Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • First Check Diagnostics LLC
      • Table 17-82: First Check Diagnostics Corporate Summary
    • Company Overview
    • Products
  • GenBio
      • Table 17-83: GenBio Corporate Summary
    • Company Overview
    • Products
  • Genedrive plc
      • Table 17-84: Genedrive Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Performance Review
      • Table 17-85: Genedrive Revenues (2017-2020) ($ millions)
  • GenePOC
      • Table 17-86: GenePOC Corporate Summary
    • Company Overview
    • Products
  • GeTein BioMedical, Inc.
      • Table 17-87: GeTein Corporate Summary
    • Company Overview
    • Products
  • GlysBy snc
      • Table 17-88: GlysBy Corporate Summary
    • Company Overview
    • Products
  • Helena Laboratories
      • Table 17-89: Helena Laboratories Corporate Summary
    • Company Overview
    • Products
  • Hemosure, Inc.
      • Table 17-90: Hemosure Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • HORIBA, Ltd.
      • Table 17-91: HORBIA Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-92: HORIBA Revenues (2017-2020) ($ millions)
  • Immunosciences Lab, Inc.
      • Table 17-93: Immunosciences Lab Corporate Summary
    • Company Overview
    • Products
  • Immunostics, Inc
      • Table 17-94: Immunostics Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • InSilixa, Inc
      • Table 17-95: InSilixa Corporate Summary
    • Company Overview
    • Products
  • Instrumentation Laboratory
      • Table 17-96: Instrumentation Laboratory Corporate Summary
    • Company Overview
    • Products
  • JAL Innovation PTE LTD
      • Table 17-97: JAL Innovation Corporate Summary
    • Company Overview
    • Products
  • Jant Pharmacal Corporation
      • Table 17-98: Jant Pharmacal Corporate Summary
    • Company Overview
    • Products
  • J. Mitra & Co Pvt. Ltd
      • Table 17-99: J Mitra Corporate Summary
    • Company Overview
    • Products
  • LamdaGen Corporation
      • Table 17-100: LamdaGen Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • LifeScan, Inc
      • Table 17-101: LifeScan Corporate Summary
    • Company Overview
    • Products
  • LifeSign, LLC
      • Table 17-102: LifeSign Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Loop Medical
      • Table 17-103: Loop Medical Corporate Summary
    • Company Overview
    • Products
  • Macherey-Nagel GmbH & Co. KG
      • Table 17-104: Macherey-Nagel Corporate Summary
    • Company Overview
    • Products
  • Magnasense Technologies
      • Table 17-105: Magnasense Technologies Corporate Summary
    • Company Overview
    • Products
  • MBio Diagnostics, Inc (LightDeck Diagnostics)
      • Table 17-106: MBio Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Medix Biochemica
      • Table 17-107: Medix Biochemica Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • MedMira, Inc
      • Table 17-108: MedMira Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Performance Review
      • Table 17-109: MedMira Revenues (2017-2020) ($ thousands)
  • Medtronic, Inc.
      • Table 17-110: Medtronic Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-111: Medtronic Revenues (2017-2020) ($ millions)
  • A. Menarini Diagnostics srl.
      • Table 17-112: Menarini Diagnostics Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Meridian Bioscience, Inc
      • Table 17-113: Meridian Bioscience Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Performance Review
      • Table 17-114: Meridian Bioscience (2017-2020) ($ millions)
  • MiCo BioMed USA
      • Table 17-115: MiCo BioMed Summary
    • Company Overview
    • Products
  • Nano-Ditech Corporation
      • Table 17-116: Nano-Ditech Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • NG Biotech
      • Table 17-117: NG Biotech Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Noble Medical, Inc
      • Table 17-118: Noble Medical Corporate Summary
    • Company Overview
    • Products
  • Nova Biomedical Corp.
      • Table 17-119: Nova Biomedical Corporate Summary
    • Company Overview
    • Products
  • NuGenerex Diagnostics
      • Table 17-120: NuGenerex Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Oasis Diagnostics Corporation
      • Table 17-121: Oasis Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Operon S.A.
      • Table 17-122: Operon Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • OPKO Health, Inc
      • Table 17-123: OPKO Health Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Performance Review
      • Table 17-124: OPKO Health Revenues (2017-2020) ($ millions)
  • OPTI Medical Systems, Inc
      • Table 17-125: OPTI Medical Corporate Summary
    • Company Overview
    • Products
  • OraSure Technologies, Inc.
      • Table 17-126: OraSure Technologies Corporate Summary
    • Company Overview
    • Products
      • Table 17-127: Selected OraSure Products
    • COVID-19
    • Performance Review
      • Table 17-128: OraSure Revenues (2017-2020) ($ millions)
  • Polymed Therapeutics Inc.
      • Table 17-129: Polymed Therapeutics Corporate Summary
    • Company Overview
    • Products
  • Polymedco, Inc
      • Table 17-130: Polymedco Corporate Summary
    • Company Overview
    • Products
  • Polymer Technologies, Inc (PTS Diagnostics)
      • Table 17-131: Polymer Technologies Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Preventis GmbH
      • Table 17-132: Preventis Corporate Summary
    • Company Overview
    • Products
  • Princeton Biomeditech Corporation
      • Table 17-133: Princeton Biomeditech Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • QuantuMDx Group Limited
      • Table 17-134: QuantuMDx Group Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Quidel Corporation
      • Table 17-135: Quidel Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-136: Quidel Revenues (2017-2020) ($ millions)
  • Radiometer Medical A/S
      • Table 17-137: Radiometer Medical Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-138: Radiometer (2017-2020) ($ millions)
  • Randox Laboratories Limited
      • Table 17-139: Randox Labs Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • RENESA UG
      • Table 17-140: RENESA UG Corporate Summary
    • Company Overview
    • Products
  • Response Biomedical Corp
      • Table 17-141: Response Biomedical Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Reszon Diagnostics International Sdn. Bhd.
      • Table 17-142: Reszon Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Rheonix, Inc
      • Table 17-143: Rheonix Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Roche Diagnostic Corporation
      • Table 17-144: Roche Diagnostic Corporate Summary
    • Company Overview
    • Products
      • Table 17-145: Roche POC Marketed Products
    • COVID-19
    • Performance Review
      • Table 17-146: Roche Diagnostics (2017-2020) ($ millions)
  • Savyon Diagnostics
      • Table 17-147: Savyon Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Sekisui Diagnostics LLC
      • Table 17-148: Sekisui Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Siemens Healthineers GmbH
      • Table 17-149: Siemens Healthineers Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-150: Siemens Healthineers (2017-2020) ($ millions)
  • Spectral Medical, Inc
      • Table 17-151: Spectral Medical Summary
    • Company Overview
  • Sysmex Corporation
      • Table 17-152: Sysmex Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-153: Sysmex (2017-2020) ($ millions)
  • TECHLAB, Inc.
      • Table 17-154: TECHLAB Corporate Summary
    • Company Overview
    • Products
  • Teco Diagnostics
      • Table 17-155: Teco Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Trinity Biotech PLC
      • Table 17-156: Trinity Biotech Corporate Summary
    • Company Overview
    • Products
    • COVID-19
    • Performance Review
      • Table 17-157: Trinity Biotech Revenue (2017-2020) ($ millions)
  • Trividia Health
      • Table 17-158: Trividia Health Corporate Summary
    • Company Overview
    • Products
  • Tulip Diagnostics Ltd
      • Table 17-159: Tulip Diagnostics Corporate Summary
    • Company Overview
  • Product
    • COVID-19
  • VedaLab
      • Table 17-160: VedaLab Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Veredus Laboratories PTE Ltd
      • Table 17-161: Veredus Labs Corporate Summary
    • Company Overview
    • Products
    • COVID-19
  • Vircell
      • Table 17-162: Vircell Corporate Summary
    • Company Overview
    • Products
  • WAMA Diagnostica
      • Table 17-163: WAMA Diagnostica Corporate Summary
    • Company Overview
    • Products
  • Wave 80 Biosciences
      • Table 17-164: Wave 80 Biosciences Corporate Summary
    • Company Overview
    • Products
  • Werfen
      • Table 17-165: Werfen Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 17-166: Werfen (2017-2020) ($ millions)

Our Knowledge Center provides access to

all market reports

Click here
to learn more

Related products

At-Home Diagnostic Testing Markets and Trends, 2023

June 6, 2023

Kalorama Information’s report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests), 2023, delves into the expanding world of at-home and home collection tests. The at-home in vitro diagnostic (IVD) testing market comprises tests that can be purchased over the counter or online, where patients collect specimens and receive results within…

Price range: $4,000.00 through $6,000.00

In Vitro Diagnostic (IVD) Trends and Market Update: March 2024

March 26, 2024

Explore the latest trends and developments in the in vitro diagnostic (IVD) market with Kalorama Information’s comprehensive report, In Vitro Diagnostic (IVD) Trends and Market Update: March 2024. Gain insights into key growth segments, industry trends, and emerging technologies shaping the future of IVD.

The report offers updated data analysis based on Kalorama Information’s annual…

Price range: $5,000.00 through $7,875.00

30-Country IVD Market Atlas, 2024

December 23, 2024

With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information presents the 30 Country In Vitro Diagnostics (IVD) Market Atlas, 2024. This quarterly updated report offers a unique approach focused on country-level research and analysis, providing a detailed analysis of major IVD segments forecasted for five years…

Price range: $5,000.00 through $7,875.00

In Vitro Diagnostic (IVD) Trends and Market Update: November 2023

As in vitro diagnostic (IVD) testing returns to its vital role in healthcare, it remains a cornerstone in medical practice, providing crucial insights for physicians, from diagnosis to precision medicine. While COVID-19 testing sees a decline, it continues to influence total revenues for 2023. In this ever-changing landscape, characterized by new products, shifts in global…

Price range: $3,750.00 through $5,625.00

In Vitro Diagnostic (IVD) Trends and Market Update: November 2023

Histology and Cytology IVD Market Update, 2024

Histology and cytology have long been essential components of pathological laboratories, offering critical insights into cells, tissues, and organs. Through histopathological examinations, a variety of diseases, including cancer, can be accurately diagnosed. Physicians rely heavily on pathological information to determine treatment plans and prognoses.

Histology and Cytology IVD Market Update, 2024 provides an in-depth competitive analysis…

Price range: $5,000.00 through $7,875.00

Histology and Cytology IVD Market Update, 2024

In Vitro Diagnostic (IVD) Trends and Market Update: March 2024

Explore the latest trends and developments in the in vitro diagnostic (IVD) market with Kalorama Information’s comprehensive report, In Vitro Diagnostic (IVD) Trends and Market Update: March 2024. Gain insights into key growth segments, industry trends, and emerging technologies shaping the future of IVD.

The report offers updated data analysis based on Kalorama Information’s annual…

Price range: $5,000.00 through $7,875.00

In Vitro Diagnostic (IVD) Trends and Market Update: March 2024